methamphetamine and nan 190

methamphetamine has been researched along with nan 190 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Majed, AA; Al-Suwailem, AK; Ginawi, OT	1
Chirwa, S; Khoshbouei, H; Stanwood, G; Swant, J	1

Other Studies

2 other study(ies) available for methamphetamine and nan 190

Article	Year
NAN-190, a possible specific antagonist for methamphetamine. Regulatory toxicology and pharmacology : RTP, 2005, Volume: 41, Issue:2 Topics: Animals; Body Temperature; Dopamine Agents; Drug Therapy, Combination; Eating; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Motor Activity; Narcotic Antagonists; Pain; Pain Measurement; Piperazines; Serotonin Antagonists	2005
Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PloS one, 2010, Jun-30, Volume: 5, Issue:6 Topics: Animals; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Methamphetamine; Mice; Mice, Inbred C57BL; Piperazines; Serotonin Antagonists; Synaptic Transmission	2010

Article

Year

NAN-190, a possible specific antagonist for methamphetamine.

Regulatory toxicology and pharmacology : RTP, 2005, Volume: 41, Issue:2

Topics: Animals; Body Temperature; Dopamine Agents; Drug Therapy, Combination; Eating; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Motor Activity; Narcotic Antagonists; Pain; Pain Measurement; Piperazines; Serotonin Antagonists

2005

Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus.

PloS one, 2010, Jun-30, Volume: 5, Issue:6

Topics: Animals; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Methamphetamine; Mice; Mice, Inbred C57BL; Piperazines; Serotonin Antagonists; Synaptic Transmission

2010